//img.uscri.be/pth/d1d8a62f3fd5a5fb417b0bf4d10a62042568a318
Cet ouvrage fait partie de la bibliothèque YouScribe
Obtenez un accès à la bibliothèque pour le lire en ligne
En savoir plus

Frost & Sullivan to Host Complimentary Web Conference: Will the U.S. Implantable Defibrillator Market Recover?

2 pages
Frost & Sullivan to Host Complimentary Web Conference: Will the U.S. Implantable Defibrillator Market Recover? PR Newswire LONDON, June 6, 2012 - Comparison of the ICD Market in the U.S. and Western Europe LONDON, June 6, 2012 /PRNewswire/ -- Western Europe and the United States are the biggest markets for Implantable Cardioverter Defibrillator. The Implantable Cardioverter Defibrillator is one of the most challenging and dynamic markets in the United States. 2011 witnessed one of the major dips in the unit sales of ICD in the U.S. Together with the decreasing pricing trends, the market for ICD in the U.S. decreased to new levels. This web conference will cover the key reasons for the dropdown of ICD unit sales in the U.S. and also a comparative analysis with some trends in the ICD market in Western European countries. Frost & Sullivan will host a complimentary web conference entitled "Will the U.S. Implantable Defibrillator Market Recover," which will take place on Wednesday 13th June 2012 at 2.00 pm BST. Research Analyst Brahadeesh Chandrasekaran has completed extensive analysis on the Implantable Cardioverter Defibrillator market. The research expert will lead a short teleconference about new findings that affect the market, followed by a live question-and-answer session. Highlights of the web conference will include heart failure, implantable cardioverter defibrillator, implantation, cardiac devices and cardiac rhythm management.
Voir plus Voir moins
Frost & Sullivan to Host Complimentary Web
Conference: Will the U.S. Implantable
Defibrillator Market Recover?
PR Newswire
LONDON, June 6, 2012
- Comparison of the ICD Market in the U.S. and Western Europe
LONDON
,
June 6, 2012
/PRNewswire/ --
Western Europe
and
the United States
are the biggest markets for Implantable Cardioverter Defibrillator. The
Implantable Cardioverter Defibrillator is one of the most challenging and
dynamic markets in
the United States
. 2011 witnessed one of the major dips in
the unit sales of ICD in the U.S. Together with the decreasing pricing trends, the
market for ICD in the U.S. decreased to new levels. This web conference will
cover the key reasons for the dropdown of ICD unit sales in the U.S. and also a
comparative analysis with some trends in the ICD market in Western European
countries.
Frost & Sullivan
will host a complimentary web conference entitled "
Will the
U.S. Implantable Defibrillator Market Recover,
" which will take place on
Wednesday
13th June 2012
at
2.00 pm BST
. Research Analyst Brahadeesh
Chandrasekaran has completed extensive analysis on the Implantable
Cardioverter Defibrillator market. The research expert will lead a short
teleconference about new findings that affect the market, followed by a live
question-and-answer session. Highlights of the web conference will include
heart failure, implantable cardioverter defibrillator, implantation, cardiac
devices and cardiac rhythm management.
To participate in this complimentary web conference, please email Janique
Morvan, Corporate Communications at janique.morvan@frost.com, with your
full contact details. Upon receipt of the above-mentioned information, a
registration link will be emailed to you.
This web conference will benefit the cardiac rhythm management industry and
manufacturers by discussing the various reasons for the market decline in 2011
and the response from physicians, electrophysiologists for implantation and
guidelines.
"The publication of non-evidence based ICD implantation has triggered down
the market for ICD in the U.S. The results from this study have been highly
influential and has raised the questions on guidelines being followed by the
medical professionals," observes Brahadeesh Chandrasekaran. "The study in
the United States
has created the curiosity at a Western European level, the
second biggest market ICDs in the world."
To receive a link of the recorded web conference and / or further information
on this research, please email Janique Morvan at janique.morvan@frost.com
with your full contact details.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with
clients to leverage visionary innovation that addresses the global challenges
and related growth opportunities that will make or break today's market